ARTIFICIAL INTELLIGENCE AND PHARMACEUTICAL INTEGRATION: TASHKENT RESEARCH INSTITUTE OF VACCINES AND SERUMS ENTERS A NEW STAGE

A meeting was held between representatives of the Pharmaceutical Industry Development Agency, the Tashkent Research Institute of Vaccines and Serums (TOSHVZITI), and specialists from InSilicoMinds, focusing on artificial intelligence and digital modeling.

🟢 During the presentation, the capabilities of quantitative analysis of biological activity (Ki, EC50, IC50, Kd), identification of biological targets, and AI-based prediction of drug efficacy were demonstrated.

📌 In addition, the following applications of in silico models were discussed:
✅ virtual bioequivalence assessment,
✅ PBPK and IVIVC modeling,
✅ optimization of formulation parameters,
✅ digital analysis of manufacturing processes.

🔬 The meeting highlighted the prospects of integrating traditional clinical approaches with digital simulation in the pharmaceutical field, as well as accelerating research and development processes in vaccine and serum production.

🌍 It was emphasized that AI-based solutions can optimize time and resources in the drug development process.

🧪 Press Service of the Tashkent Research Institute of Vaccines and Serums